# Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B

> **NCT00291616** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 52 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Pegylated Interferon-alpha2a
- **DRUG:** Thymosin alpha1 & Pegylated Interferon-alpha2a

## Key facts

- **NCT ID:** NCT00291616
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2011-07-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291616, "Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00291616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*